RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

Uncertainty surrounding Canada’s trade relationship with the United States is expected to cloud economic decision making by businesses and households for months, economists are warning, with the ...

The no annual fee More Rewards RBC Visa and More Rewards RBC Visa Infinite cards will accelerate grocery value and offer ...

RBC Capital keeps an Outperform rating and $235 price target on Alphabet (GOOGL) after its Q4 results. The quarter keeps the AI Search bear ...

Regions Financial Corp. announced the company will present at the RBC Capital Markets Global Financial Institutions Conference on March 5.

In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...

CNO Financial Group (NYSE:CNO – Get Free Report) is expected to post its quarterly earnings results after the market closes ...

February 04, 2025, 09:58 PM ET, BY Jolene W., Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...

Royal Bank of Canada closed 5.8% below its 52-week high of C$180.45, which the company reached on December 6th.

Shares of RBC Bearings Inc. (RBC) drew retail attention on Tuesday after Morgan Stanley raised its price target on the stock ...

Consistent with higher expectations for additional Bank of Canada rate cuts — following six since June, most recently a quarter-point reduction to three per cent on Jan. 29 — Canadian short-term bond ...